Catalyst Wire Dossier Catalyst Wire Dossier

Degarelix Acetate

degarelix acetate · Ipsen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Degarelix Acetate, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer [EARLY_Phase 1]

See pricing